These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

616 related items for PubMed ID: 16984688

  • 1. Cost of home and hospital care for patients with cystic fibrosis followed up in two reference medical centers in France.
    Horvais V, Touzet S, François S, Bourdy S, Bellon G, Colin C, Durieu I.
    Int J Technol Assess Health Care; 2006; 22(4):525-31. PubMed ID: 16984688
    [Abstract] [Full Text] [Related]

  • 2. Evolution of costs of care for cystic fibrosis patients after clinical guidelines implementation in a French network.
    Huot L, Durieu I, Bourdy S, Ganne C, Bellon G, Colin C, Touzet S, REMU study.
    J Cyst Fibros; 2008 Sep; 7(5):403-8. PubMed ID: 18358793
    [Abstract] [Full Text] [Related]

  • 3. Economic impact of tobramycin in patients with cystic fibrosis in a managed care population.
    Wertz DA, Chang CL, Stephenson JJ, Zhang J, Kuhn RJ.
    J Med Econ; 2011 Sep; 14(6):759-68. PubMed ID: 21942462
    [Abstract] [Full Text] [Related]

  • 4. Cost analysis of home monitoring in lung transplant recipients.
    Adam TJ, Finkelstein SM, Parente ST, Hertz MI.
    Int J Technol Assess Health Care; 2007 Sep; 23(2):216-22. PubMed ID: 17493307
    [Abstract] [Full Text] [Related]

  • 5. [Socioeconomic evaluation of the effect of rhDNase on the cost of treating infections of the respiratory tract in patients with cystic fibrosis].
    von der Schulenburg JM, Greiner W, von der Hardt H.
    Med Klin (Munich); 1995 Apr 15; 90(4):220-4. PubMed ID: 7776934
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of the ambulatory and home care record: Agreement between self-reports and administrative data.
    Guerriere DN, Ungar WJ, Corey M, Croxford R, Tranmer JE, Tullis E, Coyte PC.
    Int J Technol Assess Health Care; 2006 Apr 15; 22(2):203-10. PubMed ID: 16571196
    [Abstract] [Full Text] [Related]

  • 7. Cost savings and clinical improvement through disease management.
    Kretz SE, Pantos BS.
    J Case Manag; 1996 Apr 15; 5(4):173-81. PubMed ID: 9110702
    [Abstract] [Full Text] [Related]

  • 8. The changing direct costs of medical care for patients with HIV/AIDS, 1995-2001.
    Krentz HB, Auld MC, Gill MJ, HIV Economic Study Group.
    CMAJ; 2003 Jul 22; 169(2):106-10. PubMed ID: 12874156
    [Abstract] [Full Text] [Related]

  • 9. Cost of care and clinical condition in paediatric cystic fibrosis patients.
    Baumann U, Stocklossa C, Greiner W, von der Schulenburg JM, von der Hardt H.
    J Cyst Fibros; 2003 Jun 22; 2(2):84-90. PubMed ID: 15463855
    [Abstract] [Full Text] [Related]

  • 10. [Cost of colorectal cancer in France in 1999].
    Selke B, Durand I, Marissal JP, Chevalier D, Lebrun T.
    Gastroenterol Clin Biol; 2003 Jan 22; 27(1):22-7. PubMed ID: 12594362
    [Abstract] [Full Text] [Related]

  • 11. The economic costs of severe anaphylaxis in France: an inquiry carried out by the Allergy Vigilance Network.
    Flabbee J, Petit N, Jay N, Guénard L, Codreanu F, Mazeyrat R, Kanny G, Moneret-Vautrin DA.
    Allergy; 2008 Mar 22; 63(3):360-5. PubMed ID: 18269678
    [Abstract] [Full Text] [Related]

  • 12. Cost of outpatient medical care for children and youth with special health care needs: investigating the impact of the medical home.
    Damiano PC, Momany ET, Tyler MC, Penziner AJ, Lobas JG.
    Pediatrics; 2006 Oct 22; 118(4):e1187-94. PubMed ID: 17015507
    [Abstract] [Full Text] [Related]

  • 13. Estimating resource use and cost of prophylactic management of neutropenia with filgrastim.
    Annemans L, Van Overbeke N, Standaert B, Van Belle S.
    J Nurs Manag; 2005 May 22; 13(3):265-74. PubMed ID: 15819840
    [Abstract] [Full Text] [Related]

  • 14. Cost analysis of a home intravenous antibiotic program.
    Chamberlain TM, Lehman ME, Groh MJ, Munroe WP, Reinders TP.
    Am J Hosp Pharm; 1988 Nov 22; 45(11):2341-5. PubMed ID: 3228090
    [Abstract] [Full Text] [Related]

  • 15. A cost analysis of Outpatient Parenteral Antibiotic Therapy (OPAT): an Asian perspective.
    Yong C, Fisher DA, Sklar GE, Li SC.
    Int J Antimicrob Agents; 2009 Jan 22; 33(1):46-51. PubMed ID: 18823759
    [Abstract] [Full Text] [Related]

  • 16. [Continuous intravenous home treatment of airway infections using ceftazidime administration via portable pump in patients with cystic fibrosis; a multicenter study].
    Bakker W, Vinks AA, Mouton JW, de Jonge P, Verzijl JG, Heijerman HG.
    Ned Tijdschr Geneeskd; 1993 Nov 27; 137(48):2486-91. PubMed ID: 8272124
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Direct medical costs of chronic obstructive pulmonary disease: chronic bronchitis and emphysema.
    Wilson L, Devine EB, So K.
    Respir Med; 2000 Mar 27; 94(3):204-13. PubMed ID: 10783930
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A naturalistic comparison of amoxicillin/clavulanate extended release versus immediate release in the treatment of acute bacterial sinusitis in adults: A retrospective data analysis.
    Jackson J, Fernandes AW, Nelson W.
    Clin Ther; 2006 Sep 27; 28(9):1462-71. PubMed ID: 17062318
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.